Travere Therapeutics CFO Buys, Sells Shares in a Single Day.

On December 1, 2025, Travere Therapeutics, Inc. (TVTX) disclosed that Christopher R. Cline, the company's Chief Financial Officer, executed two transactions involving the purchase and sale of shares. Specifically, Cline acquired 20,000 shares at a price of $16.23 per share and subsequently sold an equal number of shares at a price of $35.01 per share, both transactions taking place on the aforementioned date.